A trial of clenbuterol in bronchial asthma.

18Citations
Citations of this article
17Readers
Mendeley users who have this article in their library.

Abstract

Clenbuterol is a beta 2-sympathomimetic bronchodilator. In a double-blind cross-over trial in 19 asthmatic patients with reversible airways obstruction, oral administration of both clenbuterol (40 microgram) and salbutamol (4 mg) caused significantly greater increased in peak expiratory flow rate (PEFR) than placebo, that of clenbuterol lasting longer. The patients' subjective assessment also suggested the relief of their symptoms by the active drugs. Side-effects were minimal.

Cite

CITATION STYLE

APA

Anderson, G., & Wilkins, E. (1977). A trial of clenbuterol in bronchial asthma. Thorax, 32(6), 717–719. https://doi.org/10.1136/thx.32.6.717

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free